You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Norian Corp. v. Stryker Corp.

Citations: 433 F. Supp. 2d 1051; 2004 U.S. Dist. LEXIS 29053; 2004 WL 3926002Docket: C01-00016-WHA

Court: District Court, N.D. California; December 7, 2004; Federal District Court

Narrative Opinion Summary

This case involves a patent dispute between Norian Corporation and Stryker Corporation concerning the alleged infringement of U.S. Patent No. 6,002,065, which relates to kits for preparing calcium phosphate compositions for medical use. The United States District Court for the Northern District of California granted Stryker's motion for summary judgment, determining that there was no infringement of claims 8-10 of the patent by Stryker's BoneSource® product. The court's decision hinged on the interpretation of the claim term 'a solution consisting of water and a sodium phosphate' to mean a singular sodium phosphate, thereby excluding Stryker's product, which contained two forms of sodium phosphate. The ruling was based on intrinsic evidence, including the claims and prosecution history, without resorting to extrinsic evidence. The Federal Circuit had previously reversed an order denying summary judgment on a related patent, reinforcing the interpretation that the kit's components matched the claims, despite the presence of a spatula. Ultimately, the court found no genuine factual dispute, thus granting summary judgment for Stryker, closing the case, and rendering any questions of damages moot.

Legal Issues Addressed

Claim Interpretation in Patent Law

Application: The court interpreted the patent's claim language to require a singular sodium phosphate, based on intrinsic evidence, which precluded Stryker's BoneSource® kit containing two sodium phosphates from infringement.

Reasoning: The Court agrees with the defendant's construction, concluding that intrinsic evidence sufficiently clarifies the term 'a solution consisting of water and a sodium phosphate,' without the need for extrinsic evidence.

Definition of 'Solution' in Patent Claims

Application: The court defined 'solution' as a homogeneous mixture without solid particles, distinguishing it from prior art that described a colloid.

Reasoning: The Court defines 'solution' as 'a homogeneous mixture wherein the solute is fully dissolved in the solvent.'

Interpretation of 'A' in Patent Claims

Application: The court concluded that 'a sodium phosphate' in the patent claims referred to a singular sodium phosphate, based on the claim language and prosecution history.

Reasoning: Although 'a' typically means 'one or more,' in this context, it is interpreted as singular.

Limitation of 'Consisting Of' in Patent Claims

Application: The phrase 'consisting of' was interpreted to restrict the solution to only water and sodium phosphate, excluding other compounds.

Reasoning: The phrase 'consisting of' restricts the solution to only water and sodium phosphate, excluding any other chemical compounds except trace impurities.

Summary Judgment under FRCP 56(c)

Application: Summary judgment was granted because there was no genuine issue of material fact regarding patent infringement by Stryker's product.

Reasoning: Summary Judgment is warranted when there is no genuine issue of material fact and the moving party is entitled to judgment as a matter of law, as stipulated by FRCP 56(c).